Developer docs
API playgroundTry for free, no card

Search company profiles

Mingde Capital

Full company profile

uuid002mvhg

Namestring
Mingde Capital
Legal namestring
明德资本 (Mingde Capital)
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Mingde Capital (明德资本) is a privately-held, Beijing-based financial advisory (FA) firm founded in 2022 by a team of senior investment bankers, investors, and operators led by CEO Zhou Xiang (formerly 14 years at Huaxing Capital and a stint at Legend Capital, active in China's FA industry since 2006) and Partner Hu Mingyi (former head of Huaxing's healthcare FA group, founder of Genosys). The firm operates as a partnership-model advisor providing capital market services — primarily private equity financing mandates and M&A transaction advisory — to growth-stage startups in China's new-economy sectors, with explicit focus areas including artificial intelligence (large models, embodied AI, AI for Science, AI compute), frontier technology (controlled nuclear fusion, quantum computing, brain-computer interfaces, synthetic biology), advanced manufacturing (semiconductors, aerospace, new materials, new energy), and healthcare/life sciences.

Mingde's business model is professional services revenue in the form of success-based advisory fees on closed financings and M&A deals. Disclosed deal flow includes exclusive-FA mandates such as Deep Principle's multi-round financings in AI for Science, Blue Crystal Microbes' roughly 1 billion RMB B4 round in synthetic biology, Chaiting Technology's spin-out financing exceeding 1 billion RMB in cybersecurity, Jinjing Yunhua's near-100 million RMB Series B in AI security, Kewoke Technology's hydrogen production diaphragm rounds, and Xuanjing Bio and NewPro biotech mandates. Pricing is negotiated per engagement and not publicly disclosed.

The firm is currently extremely lean (1-10 employees), operates from a single Beijing headquarters (Room 602, Fuxing International Center, Chaoyang District), and is exclusively domestic in geographic scope. Go-to-market is partner-led direct engagement, supplemented by a corporate website, a WeChat Official Account (明德资本 Mingde Capital), a public Mingde Deals showcase page, and an active recruiting channel. Mingde does not offer software products, APIs, or proprietary technology platforms; the firm's stated moat rests entirely on senior-partner pedigree, sector relationships, and execution track record rather than on technology or scale.

Short descriptiontext

Mingde Capital is a Beijing-based financial advisory firm founded in 2022 that serves China's new-economy startups across AI, frontier technology, advanced manufacturing, and healthcare by providing exclusive private financing and M&A advisory mandates through a partner-led engagement model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBeijing, China
HQ citystring
Beijing
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
financial advisory services, private equity financing, mergers and acquisitions advisory, capital market advisory, venture capital advisory
Industry3 codes
PRIMARYFSAEAGAC
Capital Raising Advisory (Equity & Equity-Linked)
SECONDARYBPAHADAB
Corporate Finance & Capital Advisory
SECONDARYBPAHAOAL
Capital Markets Advisory (IPO Readiness, SPAC, ECM/DCM Advisory)
NAICS code1 code
  • Securities, Commodity Contracts, and Other Financial Investments and Related Activities523
SIC code1 code
  • Security Brokers, Dealers & Flotation Companies6211
Product category
Financial Advisory Services
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Financial Advisory Fees
TypeProfessional Services
Description

Mingde Capital generates revenue through financial advisory fees for providing capital market services to startups, including private equity financing and M&A transaction facilitation. The firm operates as a Financial Advisor (FA) serving new economy companies seeking growth capital.

mingdecapital.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Mingde Capital provides financial advisory services to startups and growth-stage companies in new-economy sectors (AI, frontier technology, advanced manufacturing). The firm acts as exclusive financial advisor on private equity financing rounds and M&A transactions, with senior partners deeply involved in every engagement, delivering long-term, objective capital market counsel and investor access.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 500+ closed transactions across sectors and stages
+2 more records
Product overview1 text field

Mingde Capital is a financial advisory (FA) firm founded in 2022, providing capital market advisory services to startups and emerging companies. The company operates primarily as a service-based business rather than a software product company. Their core offering is financial advisory services helping companies secure financing and navigate M&A transactions. The company does not appear to offer discrete software products or technology platforms — all extracted content relates to their advisory services and deal-making activities.

Product and service4 records
1Financial Advisory Services (Private Equity Financing)
CategoryFinancial Advisory — Private Equity Financing
Description

Exclusive financial advisory for private equity financing rounds (Pre-Seed through Pre-IPO) for new-economy startups in AI, frontier technology, advanced manufacturing, and healthcare/life sciences. The firm is engaged on a per-deal basis, supports valuation negotiations, investor sourcing, and closing, and accumulates a multi-round track record with many clients (e.g., Deep Principle, Blue Crystal Microbes, Bai Yao Technology, Xuanjing Bio, Innoway Qixing, Yinghua Chenrui, Jinjing Yunhua).

2Financial Advisory Services (M&A Transactions)
CategoryFinancial Advisory — Mergers and Acquisitions
Description

M&A transaction advisory and execution for startup and growth-stage clients, including split-financing structures and divestiture-related capital advisory (e.g., Chaiting Technology's split financing exceeding RMB 1 billion), delivered by senior partners with multi-decade track records from Huaxing Capital.

3Strategic Capital Markets Advisory
CategoryStrategic Financial Advisory
Description

Long-term, objective strategic counsel on capital markets, including financing planning, investor positioning, and sustainable growth financing strategies for new-economy clients, designed to address capital cycles and to surface and support future industry leaders over multi-year horizons.

4Healthcare and Life Sciences Financial Advisory
CategoryFinancial Advisory — Healthcare and Life Sciences
Description

Sector-specialized financial advisory for biotech, synthetic biology, pharma R&D, and medical device startups, led by Partner Hu Mingyi; covers financing rounds for clients such as Blue Crystal Microbes, Bai Yao Technology, Xuanjing Bio, Yinghua Chenrui, NewPro, and Shi Qi Biochemical, applying domain expertise to navigate regulatory and long R&D-cycle realities of healthcare.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global independent advisory firm with strong M&A and capital-raising practices; comparable to Mingde Capital in senior-led, relationship-driven advisory execution and growth-company financing focus, but operating at much larger scale and serving cross-border mandates Mingde does not cover from China.

2CICC (中金公司)
TypeBroad incumbent
Description

China's flagship full-service investment bank with broad coverage including ECM, M&A and growth-equity advisory — overlaps with Mingde Capital on financing advisory to Chinese growth companies, though CICC operates as a much broader franchise and competes for larger-cap and cross-border mandates Mingde does not service.

3China Renaissance (华兴资本)
TypeDirect peer
Description

China's leading independent boutique advisor and Mingde Capital's most direct competitor; Mingde's founders (Zhou Xiang and Hu Mingyi) were former senior leaders at China Renaissance's financial advisory business unit, and the firms compete for the same VC/PE financing and M&A mandates across AI, frontier tech and advanced manufacturing.

TypeDirect peer
Description

Long-standing Chinese boutique advisor focused on growth-stage and new-economy financings in healthcare, consumer, and technology — directly comparable to Mingde Capital in target clients (Chinese VC-backed startups), service mix (PE financing + M&A advisory), and reputation-driven, senior-led delivery model.

5Lattice Capital (光源资本)
TypeDirect peer
Description

Beijing-based Chinese FA boutique advising startups on growth-equity financings and strategic transactions; competes head-to-head with Mingde for AI, SaaS and frontier-tech mandates and shares a similar boutique, partner-led approach to serving new-economy issuers.

TypeDirect peer
Description

One of China's earliest financial advisor brands, serving new-economy and TMT clients with a mix of growth-equity FA, M&A advisory and fund services — comparable to Mingde Capital in that both target Chinese growth-company issuers and compete on premium, relationship-driven mandates.

TypeDirect peer
Description

Chinese boutique advisor focused on venture and growth-stage financing rounds for technology-enabled companies; directly comparable to Mingde Capital in deal-size sweet spot (Series A through C), sector overlap (AI, deep tech) and exclusive-FA mandate model.

8Zero2IPO Group (清科)
TypeEmerging player
Description

China-based venture research, data and FA platform serving PE/VC transactions; comparable to Mingde Capital as a Chinese FA provider to growth-stage startups, but distinguished by its research, ranking and database franchise plus broader scope beyond pure-play advisory.

9Thaihot Capital (泰合资本)
TypeDirect peer
Description

Boutique Chinese FA firm focused on growth-stage rounds and M&A for new-economy companies in consumer, healthcare and tech; comparable to Mingde Capital in target client (Chinese VC-backed growth companies), exclusive-FA positioning, and senior-partner-led engagement model.

1036Kr Capital
TypeEmerging player
Description

Chinese tech-media-plus-FA platform that connects startups to investors and provides financial advisory on venture and growth-stage rounds; comparable to Mingde Capital as a Chinese FA intermediary for new-economy issuers, with a media-driven origination channel that Mingde lacks.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers19 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mingde Capital

Financial Advisory Servicesmingdecapital.com

Mingde Capital is a Beijing-based financial advisory firm founded in 2022 that serves China's new-economy startups across AI, frontier technology, advanced manufacturing, and healthcare by providing exclusive private financing and M&A advisory mandates through a partner-led engagement model.

What Mingde Capital does

Mingde Capital (明德资本) is a privately-held, Beijing-based financial advisory (FA) firm founded in 2022 by a team of senior investment bankers, investors, and operators led by CEO Zhou Xiang (formerly 14 years at Huaxing Capital and a stint at Legend Capital, active in China's FA industry since 2006) and Partner Hu Mingyi (former head of Huaxing's healthcare FA group, founder of Genosys). The firm operates as a partnership-model advisor providing capital market services — primarily private equity financing mandates and M&A transaction advisory — to growth-stage startups in China's new-economy sectors, with explicit focus areas including artificial intelligence (large models, embodied AI, AI for Science, AI compute), frontier technology (controlled nuclear fusion, quantum computing, brain-computer interfaces, synthetic biology), advanced manufacturing (semiconductors, aerospace, new materials, new energy), and healthcare/life sciences.

Mingde's business model is professional services revenue in the form of success-based advisory fees on closed financings and M&A deals. Disclosed deal flow includes exclusive-FA mandates such as Deep Principle's multi-round financings in AI for Science, Blue Crystal Microbes' roughly 1 billion RMB B4 round in synthetic biology, Chaiting Technology's spin-out financing exceeding 1 billion RMB in cybersecurity, Jinjing Yunhua's near-100 million RMB Series B in AI security, Kewoke Technology's hydrogen production diaphragm rounds, and Xuanjing Bio and NewPro biotech mandates. Pricing is negotiated per engagement and not publicly disclosed.

The firm is currently extremely lean (1-10 employees), operates from a single Beijing headquarters (Room 602, Fuxing International Center, Chaoyang District), and is exclusively domestic in geographic scope. Go-to-market is partner-led direct engagement, supplemented by a corporate website, a WeChat Official Account (明德资本 Mingde Capital), a public Mingde Deals showcase page, and an active recruiting channel. Mingde does not offer software products, APIs, or proprietary technology platforms; the firm's stated moat rests entirely on senior-partner pedigree, sector relationships, and execution track record rather than on technology or scale.

Mingde Capital firmographics

Firmographics
Name
Mingde Capital
Legal name
明德资本 (Mingde Capital)
Website
https://mingdecapital.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
Mingde Capital is a Beijing-based financial advisory firm founded in 2022 that serves China's new-economy startups across AI, frontier technology, advanced manufacturing, and healthcare by providing exclusive private financing and M&A advisory mandates through a partner-led engagement model.
Ownership category
akta.pro rank

Mingde Capital industry classification

Industry
Product category
Financial Advisory Services
NAICS
Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)
SIC
Security Brokers, Dealers & Flotation Companies (6211)
akta.pro industry
PRIMARYFSAEAGAC
Capital Raising Advisory (Equity & Equity-Linked)
SECONDARYBPAHADAB
Corporate Finance & Capital Advisory
SECONDARYBPAHAOAL
Capital Markets Advisory (IPO Readiness, SPAC, ECM/DCM Advisory)

Keywords

  • Financial advisory services
  • Private equity financing
  • Mergers and acquisitions advisory
  • Capital market advisory
  • Venture capital advisory

Where Mingde Capital is headquartered

Location

Headquarters

HQ city
Beijing
HQ country
China
HQ region
Asia

Offices1 record

Markets served

Mingde Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

Revenue model

  1. Financial Advisory Fees: Mingde Capital generates revenue through financial advisory fees for providing capital market services to startups, including private equity financing and M&A transaction facilitation. The firm operates as a Financial Advisor (FA) serving new economy companies seeking growth capital.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Mingde Capital product offering

Product offering

Core offering

Mingde Capital provides financial advisory services to startups and growth-stage companies in new-economy sectors (AI, frontier technology, advanced manufacturing). The firm acts as exclusive financial advisor on private equity financing rounds and M&A transactions, with senior partners deeply involved in every engagement, delivering long-term, objective capital market counsel and investor access.

Product overview

Mingde Capital is a financial advisory (FA) firm founded in 2022, providing capital market advisory services to startups and emerging companies. The company operates primarily as a service-based business rather than a software product company. Their core offering is financial advisory services helping companies secure financing and navigate M&A transactions. The company does not appear to offer discrete software products or technology platforms — all extracted content relates to their advisory services and deal-making activities.

Differentiator

Problem solved

Functional benefit

Products and services

  • Financial Advisory Services (Private Equity Financing) Exclusive financial advisory for private equity financing rounds (Pre-Seed through Pre-IPO) for new-economy startups in AI, frontier technology, advanced manufacturing, and healthcare/life sciences. The firm is engaged on a per-deal basis, supports valuation negotiations, investor sourcing, and closing, and accumulates a multi-round track record with many clients (e.g., Deep Principle, Blue Crystal Microbes, Bai Yao Technology, Xuanjing Bio, Innoway Qixing, Yinghua Chenrui, Jinjing Yunhua).
  • Financial Advisory Services (M&A Transactions) M&A transaction advisory and execution for startup and growth-stage clients, including split-financing structures and divestiture-related capital advisory (e.g., Chaiting Technology's split financing exceeding RMB 1 billion), delivered by senior partners with multi-decade track records from Huaxing Capital.
  • Strategic Capital Markets Advisory Long-term, objective strategic counsel on capital markets, including financing planning, investor positioning, and sustainable growth financing strategies for new-economy clients, designed to address capital cycles and to surface and support future industry leaders over multi-year horizons.
  • Healthcare and Life Sciences Financial Advisory Sector-specialized financial advisory for biotech, synthetic biology, pharma R&D, and medical device startups, led by Partner Hu Mingyi; covers financing rounds for clients such as Blue Crystal Microbes, Bai Yao Technology, Xuanjing Bio, Yinghua Chenrui, NewPro, and Shi Qi Biochemical, applying domain expertise to navigate regulatory and long R&D-cycle realities of healthcare.

Quantifiable outcome

  • 500+ closed transactions across sectors and stages
  • +2 more outcomes

Companies that use Mingde Capital

Customer profile

Named customers19 records

Segments4 records

Ideal customer profiles2 records

Mingde Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Mingde Capital partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Mingde Capital competitors and assessment

Company assessment

Broad incumbents

  • Houlihan Lokey: Global independent advisory firm with strong M&A and capital-raising practices; comparable to Mingde Capital in senior-led, relationship-driven advisory execution and growth-company financing focus, but operating at much larger scale and serving cross-border mandates Mingde does not cover from China.
  • CICC (中金公司): China's flagship full-service investment bank with broad coverage including ECM, M&A and growth-equity advisory — overlaps with Mingde Capital on financing advisory to Chinese growth companies, though CICC operates as a much broader franchise and competes for larger-cap and cross-border mandates Mingde does not service.

Direct peers

  • China Renaissance (华兴资本): China's leading independent boutique advisor and Mingde Capital's most direct competitor; Mingde's founders (Zhou Xiang and Hu Mingyi) were former senior leaders at China Renaissance's financial advisory business unit, and the firms compete for the same VC/PE financing and M&A mandates across AI, frontier tech and advanced manufacturing.
  • eCapital (易凯资本): Long-standing Chinese boutique advisor focused on growth-stage and new-economy financings in healthcare, consumer, and technology — directly comparable to Mingde Capital in target clients (Chinese VC-backed startups), service mix (PE financing + M&A advisory), and reputation-driven, senior-led delivery model.
  • Lattice Capital (光源资本): Beijing-based Chinese FA boutique advising startups on growth-equity financings and strategic transactions; competes head-to-head with Mingde for AI, SaaS and frontier-tech mandates and shares a similar boutique, partner-led approach to serving new-economy issuers.
  • Hina Group (汉能资本): One of China's earliest financial advisor brands, serving new-economy and TMT clients with a mix of growth-equity FA, M&A advisory and fund services — comparable to Mingde Capital in that both target Chinese growth-company issuers and compete on premium, relationship-driven mandates.
  • Index Capital (指数资本): Chinese boutique advisor focused on venture and growth-stage financing rounds for technology-enabled companies; directly comparable to Mingde Capital in deal-size sweet spot (Series A through C), sector overlap (AI, deep tech) and exclusive-FA mandate model.
  • Thaihot Capital (泰合资本): Boutique Chinese FA firm focused on growth-stage rounds and M&A for new-economy companies in consumer, healthcare and tech; comparable to Mingde Capital in target client (Chinese VC-backed growth companies), exclusive-FA positioning, and senior-partner-led engagement model.

Emerging players

  • Zero2IPO Group (清科): China-based venture research, data and FA platform serving PE/VC transactions; comparable to Mingde Capital as a Chinese FA provider to growth-stage startups, but distinguished by its research, ranking and database franchise plus broader scope beyond pure-play advisory.
  • 36Kr Capital: Chinese tech-media-plus-FA platform that connects startups to investors and provides financial advisory on venture and growth-stage rounds; comparable to Mingde Capital as a Chinese FA intermediary for new-economy issuers, with a media-driven origination channel that Mingde lacks.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Mingde Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mingde Capital leadership team

Management profile

Number of profiles

Profiles2 records

Mingde Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mingde Capital M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mingde Capital

What does Mingde Capital do?

Mingde Capital provides financial advisory services to startups and growth-stage companies in new-economy sectors (AI, frontier technology, advanced manufacturing). The firm acts as exclusive financial advisor on private equity financing rounds and M&A transactions, with senior partners deeply involved in every engagement, delivering long-term, objective capital market counsel and investor access.

Is Mingde Capital a public or private company?

Mingde Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Mingde Capital founded?

Mingde Capital was founded in 2022. It employs 1 to 10 people.

Where is Mingde Capital based?

Mingde Capital is headquartered in Beijing, China, in the Asia region.

How does Mingde Capital make money?

One revenue line is on record: financial Advisory Fees.

Who are Mingde Capital's main competitors?

Broad incumbents on record are Houlihan Lokey and CICC (中金公司). Direct peers are China Renaissance (华兴资本), eCapital (易凯资本), Lattice Capital (光源资本), Hina Group (汉能资本), Index Capital (指数资本) and Thaihot Capital (泰合资本). Emerging players are Zero2IPO Group (清科) and 36Kr Capital.

Does Mingde Capital have an API?

No public API is recorded for Mingde Capital.

What industry is Mingde Capital in?

Mingde Capital's product category is Financial Advisory Services. Its primary akta.pro industry code is FSAEAGAC, Capital Raising Advisory (Equity & Equity-Linked), with a secondary code of BPAHADAB, Corporate Finance & Capital Advisory. Its NAICS code is 523 and its SIC code is 6211.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pedaily上海新苡萃生物(NewPro)完成数千万元PreA轮融资,深耕合成生物技术Shanghai NewPro Bioworks Co., Ltd. recently completed a Pre-A round financing of several tens of millions RMB, co-led by Shanghai Guotou Pioneer and Aochuang Pioneer Fund, with Mingde Capital serving as exclusive financial advisor. The proceeds will be used to accelerate lactoferrin regulatory approval in China, expand FDA Self-GRAS certified products into international markets, and construct large-scale production facilities for functional food proteins. The company leverages its proprietary FlexBaseTM industrial chassis transformation technology and NeuroBrewTM intelligent precision fermentation process to produce high-value proteins through biomanufacturing.Fastdata极数上海饮品原料及添加剂研发商NewPro获得数千万人民币Pre-A轮融资 – Fastdata极数NewPro, a Shanghai beverage raw materials and additives developer, raised tens of millions of RMB in a Pre-A round led by Shanghai Guotou Xian Dao and Aochuang Xian Dao Fund, with Mingde Capital as exclusive financial advisor. The company focuses on synthetic biology and precision fermentation for functional dairy proteins like lactoferrin and casein.Fastdata极数北京物理智能(Physical AI)研发商深度机智再获数亿元融资 – Fastdata极数Deepcybo, a Beijing Physical AI developer, received hundreds of millions in financing led by the China Life Yangtze River Delta Science and Technology Innovation Fund. Existing shareholders including PwC Capital and Chengtong Science and Technology Innovation Fund increased their stakes, and over ten market-oriented institutions and industrial capital joined the round.QqJinjing Yunhua successfully raised nearly 100 million yuan, and Anxin 'CyberGPT' leads the trend in the cybersecurity industry.Jin Jing Yun Hua completed a nearly 100 million yuan Series B financing round led by Qi An Investment and Yongxin Zhicheng, with Mingde Capital serving as the financial advisor. The company simultaneously announced the launch of 'CyberGPT', an AI-driven security large model designed to automate threat detection and response in the cybersecurity sector. This funding will support the company's strategic expansion in artificial intelligence applications and product research and development.